SQZ Biotech
Enabling the Next Generation of Cell Therapies.
Launch date
Employees
Market cap
CAD547k
Enterprise valuation
(CAD20m) (Public information from Jul 2023)
Share price
$0.057 SQZ
Watertown Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$15.0k | Seed | ||
$100k | Grant | ||
$5.0m | Series A | ||
* | $1.2m | Grant | |
$16.0m | Series B | ||
$4.0m | Series B | ||
N/A | Early VC | ||
* | $72.0m | Series C | |
| N/A | $71.3m | Early VC | |
* | $65.0m | Series D | |
| N/A | $91.3m | IPO | |
| N/A | $60.0m | Post IPO Equity | |
$2.0m | Grant | ||
* | N/A | Acquisition | |
| Total Funding | CAD323m | ||
Related Content
Recent News about SQZ Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.